Conference call and webcast at 8:30am ET CHICAGO --(BUSINESS WIRE)--Feb. 23, 2023-- Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies,